Form 4: Stryker Corp Executive Spencer S. Stiles Granted Stock Options

Spencer S. Stiles, a Group President at Stryker Corp, was granted employee stock options on February 5, 2025, under the company's 2011 Long-Term Incentive Plan.

Summary

• On February 5, 2025, Spencer S. Stiles, a Group President at Stryker Corp, was granted employee stock options.
• The options allow Stiles to purchase 13,458 shares of Stryker's common stock at a price of $392.39 per share.
• The options were granted under the Stryker Corporation 2011 Long-Term Incentive Plan.
• The options vest in five equal installments, with 20% becoming exercisable on each of the first five anniversaries of the grant date.
• The options expire on February 4, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed favorably as it aligns management's interests with shareholders.

Positives

• The granting of stock options aligns the executive's interests with those of the shareholders, incentivizing performance and long-term value creation.

Industry Context

Stock options are a common form of executive compensation in the medical device industry, used to attract, retain, and incentivize key personnel.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the medical device industry, similar to practices at companies like Medtronic, Johnson & Johnson, and Boston Scientific.
• The vesting schedule of 20% per year over five years is also a typical arrangement.

Stakeholder Impact

• Shareholders may view the stock option grant positively as it incentivizes management to improve company performance.
• The executive benefits from the potential to profit from future stock price appreciation.

Key Dates